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SUMMARY
Northern Ireland remains at the top of the world mortality league for ischaemic
heart disease. The Province is providing a centre for the World Health
Organisation's MONICA Project. Registration of coronary heart disease events
began in 1983 and the first of three population surveys took place in 1983 -4.
A total of 2,361 men and women aged 25-64 years was screened. Subjects
were shorter and heavier than theirfellow citizens in GreatBritain. The estimated
mean cholesterol levels in the 25-64- year- old population (5 80 mmol/I in
males and 5 85 mmol/I in females) were similar to those reported from Great
Britain. Although mean systolic blood pressures were lower, mild diastolic
hypertension was considerably more common; cigarette smoking levels were
similar. The results were consistent with those expected for an area with a high
coronary heart disease mortality, with more than 80% of subjects being at
increased risk in terms of the three major factors (cigarette smoking,
hypertension and raised cholesterol).
Public concern about coronary heart disease has grown and recently the
Department of Health and Social Services (NI) has launched a 10-year
prevention programme which will primarily employ a population approach.
INTRODUCTION
Northern Ireland remains at the top of the world mortality league for ischaemic
heart disease (ICD No 410-414). The age standardised mortality rate per
100,000 (40-69 years) for 1986 was 557 in males and 169 in females.'
The respective figures in Scotland were 542 and 180.2 These countries now
head the world mortality league as a continued decline has been reported
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from Finland.3 Belfast and its environs form a centre for the World Health
Organisation -co -ordinated MONICA (MONItoring of trends and determinants in
CArdiovascular disease) Project.4 The MONICA Project is being carried out in
more than 30 centres throughout the world and will last for a decade. It is in two
parts: registration of coronary heart disease events (fatal and non-fatal) will
establish trends in incidence, and screening of independent samples of the
population on three occasions will monitor risk-factor levels. In this way, possible
changes in incidence and case fatality may be analysed in relation to risk-factor
changes within communities, and across the many centres. The study area
comprises the Belfast, Castlereagh, North Down and Ards Health Districts of the
Eastern Health and Social Services Board area with a total population of 499,111
and a target population, aged 25 -64 years, of 223,575.5 Registration began on
1 January 1983 and the first survey took place from October 1983 to September
1984.
METHODS
The MONICA Project requires that at least 200 persons of each sex should be
screened for risk-factor levels in each 10-year age group between 25 and
64 years. Specific assumptions are made for each of the major risk-factors
concerning the magnitude of the true change which should be detectable, and
the sample size was estimated to give a high power to detect these changes as
statistically significant. Screening is to be carried out on three well separated
occasions during the study period. Various core (essential) items are: smoking
(self-reported, validated by serum thiocyanate estimation), blood pressure,
serum cholesterol, height and weight. Other factors strongly recommended for
inclusion are high density lipoprotein cholesterol (HDL-cholesterol) and gamma
glutamyl transferase. Each centre is free to study other factors and there are
several MONICA optional studies, eg nutrition, exercise, medical care, drugs and
psychosocial factors.
The sampling frame selected for the survey was the Northern Ireland Central
Services Agency's general practitioner lists. A stratified random sample of 5,000
subjects was chosen with eight strata defined by age group and sex. This sample
size was sufficient to give almost 400 subjects per stratum assuming a response
rate of 75% and an ineligibility rate of 15%. Subjects were initially contacted by
letter, with an introductory questionnaire seeking preferences for times and
clinics. In the event of envelopes being returned undelivered or a non -response,
general practitioners' receptionists were approached and asked to check
addresses and, when necessary, subjects were visited at home. Subjects were
seen in community health suites of health centres throughout the area. Arranging
clinics in Belfast and certain other areas was a problem as subjects were some-
times reluctant to travel out of their localities. A strict protocol was adhered to for
all screening procedures. Height and weight were measured in a standardised
way, and blood pressure (diastolic phase V) was taken before venipuncture using
the Hawksley random zero sphygmomanometer. Two readings were obtained
when the subject was sitting and relaxed for five minutes. Where appropriate, an
over-sized cuff was used. Periodic checks for digit preference on the uncorrected
readings were made and recorders were retrained and recertified as necessary.
As well as employing internal quality control procedures, total cholesterol,
HDL-cholesterol and thiocyanate estimation were subject to external quality
control through the World Health Organisation reference laboratory in Prague.
Centrifuging and separation took place within three hours of venipuncture.
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Cholesterol was estimated using the enzymatic CHOD-PAP method6 and
precipitation for HDL-cholesterol estimation employed phosphotungstic Mg+ +
reagents.7 Thiocyanate was measured using Butts' method. Subjects were
requested not to eat a heavy meal during the few hours before the examination
(semi -fasting).
Estimates of means and proportions for the 25-64-year-old population were
obtained by appropriate weighting of the estimates from the separate age strata.
RESULTS
Considerable difficulty was encountered in tracing subjects because of the large
shifts of population which have occurred over the years of civil disturbance.
Subjects were only classified as ineligible if at least two visits to the last known
address and reference to other sources failed to establish that the person was
alive and living in the study area: 1,620 (32%) were so classified.
A total of 2,361 subjects were screened giving an overall response rate of 70%;
non-response records were completed for 82% of the 1,019 non-responders.
Response rateswere higherin theolder agegroups. The unemployed were under-
represented in the sample whereas skilled workers were over-represented.5
The mean height of men in the population was estimated as 172-9 (SE 0-2) cm
and of women, 159-3 (SE 0-2) cm. Younger subjects were taller than older
subjects and this was more marked in males. The estimated mean weight in
the male population was 76-6 (SE 0-4) kg and in the female population
63-7 (SE 0-3) kg; the weights were greatest in the 45-54 year age group in
both sexes. The distribution of body mass index by age and sex is shown in
Table 1. In both sexes, the percentage carrying excess weight (body mass index
[BMI] >25 kg/m2) increased with age. Inthethree younger agegroupsa greater
proportion of males than of females bore excess weight. These differences
disappeared in the older age group. Over half of the men in the sample, 53-6%,
were classified as carrying excess weight compared with 44-4% of females.
A large proportion of men and women in the sample claimed to take no leisure
time exercise: 43-5% of the males and 47-3% of the females.
TABLE I
Distribution ofbody mass index (kg/rm2)
Male Female
Age n Over- Obese Excess n Over- Obese Excess
(years) weight weight weight weight
25-34 241 34-0 6-2 40-2 267 17-2 9-4 26-6
35-44 276 40-9 12-0 52-9 294 30-3 10-9 41-2
45-54 334 48-8 11-7 60-5 322 35-1 15-8 50-9
55-64 314 48-1 8-9 57-0 308 38-6 17-5 56-1
Overweight:- BMI >25 < = 30 kg/rm2
Obese:- BMI >30 kg/rm2
Excess weight:- BMI >25 kg/M2
Missing values:- 3 male, 2 female
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The distribution of total serum cholesterol is shown in Table 11. Although females
had a lower cholesterol than males in the two younger age groups, the converse
was true in the older groups. The biggest increase between age groups was
seen in males from the 25 -34 to the 35 -44 age group and in females from the
35 -44 to the 45 - 54 year age group. In the 55 -64 year age group, cholesterol
levels were markedly higher in females than males. Across all age groups,
however, the estimated mean levels for the population were similar in the sexes:
5-80 (SE 0 03) mmol/l in males and 5-85 (SE 0 03) mmol/l in females. Taking
an upper limit of 6 70 mmol/1, 21 % of males and 24% of females in the sample
were identified as having abnormal levels. Applying an upper limit of 5-20
mmol/l, as recommended by one authority,8 identified 71 % of males and 69%
of females to be at increased risk and in the 55-64 year age group, 80% of
males and 91 % of females were so identified.
TABLE II
Serum total cholesterol levels (mmol/) *
Male Female
Age n Mean SD Percentile n Mean SD Percentile
(years) 5th 95th 5th 95th
25-34 233 5-22 0 97 3 79 6-72 264 4 99 091 3.59 6-48
35-44 276 5 95 1-10 4-32 7-58 291 5-44 0*93 4*04 7-05
45-54 328 6*02 1-08 4X34 7-89 320 6-26 1-18 4 49 8-05
55-64 312 6-12 1-05 4-63 7-83 303 6-74 1-14 4-84 8-71
*Conversion: Si to traditional units -1 mmol/l = 38-6 mg/ 100 ml (approximately)
Missing values:- 19 male, 15 female
The distribution of HDL-cholesterol in men and women is shown in Table 111.
The mean levels remained fairly constant across the age groups, but were
considerably lower in males than in females. The estimated population means
were 1-14 (SE 0.01) mmol/l and 1-40 (SE 0-01) mmol/l, respectively.
TABLE Ill
HDL cholesterol levels (mmol/l) *
Male Female
Age n Mean SD Percentile n Mean SD Percentile
(years) 5th 95th 5th 95th
25-34 231 1-16 0-26 0-79 1-67 257 1-39 0-31 0-88 1-91
35-44 270 1-14 0 28 0-75 1-63 285 1-38 0-31 0-87 1-94
45-54 321 1-12 0-28 0-75 1-60 313 1-44 0-39 0-90 2-20
55-64 304 1-13 0-29 0-73 1-69 295 1-40 0-34 0-87 2-02
*Conversion: Si to traditional units -1 mmol/i = 38-6 mg/100 ml (approximately)
Missing values:- 42 male, 43 female
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The distribution of current cigarette smoking by age and sex is given in Table IV.
Just over a third of men and women in the sample were cigarette smokers,
even if only occasional. The estimated proportions of cigarette smokers in the
25-64-year-old male and female population were 35-8% (SE 1-4) and 36-3%
(SE 1-4), respectively. A further 13-2% of males in the sample were cigar
smokers and of these 70% had been cigarette smokers in the past. A higher
proportion of females in the sample had never smoked cigarettes: 45-3% as
opposed to 29-2 % of males; and a higher proportion of males were ex-smokers:
35-4% as opposed to 18-6% of females. Male smokers smoked on average
18-8 cigarettes per day and female smokers 15-8. Only 16-0% of male smokers
in the sample used low -tar -content cigarettes as opposed to 32-5 % of female
smokers. There were a further 131 individuals who denied smoking (5-5% of all
subjects) but had a serum thiocyanate level > 50 mmol/I, of whom 37 (1-6% of




Age n Current Ex- Never n Current Ex- Never
(years) % % % % % %
25-34 241 36-9 23-7 39-4 268 39-9 20-6 39-6
35-44 277 39-0 27-8 33-2 295 35-9 17-0 47-1
45-54 336 33-0 39-3 27-7 322 33-2 18-6 48-1
55-64 314 33-8 46-8 19-4 308 36-0 18-5 45-5
Tables V and VI show the distribution of systolic and diastolic blood pressures.
Although females had lower systolic blood pressure than males in the younger
age groups, by middle age this difference had almost disappeared: this held to
a lesser extent for diastolic blood pressure. The estimated mean systolic and
diastolic blood pressures in the male population were 133- 1 (SE 0-5) mmHg and
82-0 (SE 0-3)mmHg, respectively. Forthefemale population, thecorresponding
figures were 128-6 (SE 0-5) mmHg and 77-5 (SE 0-3) mmHg. Applying cut-off
TABLE V
Systolic blood pressure (mmHg)
Male Female
Age n Mean SD Percentile n Mean SD Percentile
(years) 5th 95th 5th 95th
25-34 240 126-6 12-8 106-5 147-0 268 114-5 12-7 94-0 134-7
35-44 277 127-2 15-5 104-0 153-0 294 120-9 14-9 100-0 145-0
45-54 336 135-0 21-0 106-5 171-5 322 134-4 21-7 104-0 173-0
55-64 314 145-5 22-6 111-5 187-0 307 144-9 23-7 108-5 184-5
Missing values:- 1 male, 2 female
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TABLE VI
Diastolic blood pressure (mmHg)
Male Female
Age n Mean SD Percentile n Mean SD Percentile
(years) 5th 95th 5th 95th
25-34 240 77-4 10-6 59-5 94-0 268 70-9 9-5 54- 7 87-5
35-44 277 81-8 11-7 63-5 102-0 294 75-1 10-3 61-0 94-0
45-54 336 85-0 12-3 65-7 106-0 322 81-8 11-7 64-5 104-0
55-64 314 84-7 12-3 67-0 105-0 307 82-6 12-0 65-5 102-0
Missing values:- 1 male, 2 female
pointsofsystolic 2 140 mmHg and diastolic >90 mmHg identified 213 (18-2%)
males and 141 (11-8%) femalesinthe sampleashaving abnormal blood pressure.
Of these, 33 males (15-5%) and 37 females (26-2%) were on antihypertensive
drugs. A further 33 males and 56 females were on antihypertensive drugs and
were normotensive.
Taking risk factors in combination (cholesterol 5-2 mmol/l, cigarette smoking,
systolic blood pressure > 140 mmHg and diastolic . 90 mmHg, or controlled on
antihypertensives), 82-5% of men and 80-6% of women in the sample had at
least one factor present; 39-4% of men and 37-0% of women had two or more
factors.
DISCUSSION
The response rate achieved in the present study was 70% compared with 74% in
the Medical Research Council trial of treatment of mild hypertension9 and 78%
in the British Regional Heart Study.'0 The latter studies, however, were based on
selected general practices.
Both male and female subjects were shorter than their counterparts in Great
Britain:11 males on average were 0-5cm and females 1-3cm shorter. The
difference was most marked in the younger age groups, possibly suggesting a
difference in the rate of nutritional change between the two populations. Our
subjects were also heavier: males on average by 1-6kg and females by 0-7kg.
The differences were greatest in the middle (35 -54) age groups. The body mass
indices, which are largely uncorrelated with height,12 revealed that 53-6% of
males carried excess weight as opposed to 44-9% in Great Britain. In females the
respective figures were 44-4% and 35-5%. In comparison with Great Britain, the
higher proportion of subjects with excess weight was most striking in the 35 -54
year olds. Increased weight contributes to coronary heart disease and this may
affect serum cholesterol levels and blood pressure. Obesity has been reported to
be associated with an increased production of low density lipoproteins.13
The mean total cholesterol level of 6-10 mmol/1 for males aged 40-59 in our
study was similar to that in the British Regional Heart Study (6-30 mmol/1).'4
There were differences in the biochemical methodology, and the Regional Heart
Study samples were taken non-fasting, as opposed to semi-fasting in our study.
Moreover, the British Regional Heart Study included northern regions in which
the incidence of coronary heart disease is similar to our own. In the 40-59 year
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age group in the British Risk Factor Prevalence Study, a mean of 6-0 mmol/l was
found.15The latterstudy, using cut-offpointsof >6-5, >5-7 and >5-2 mmol/l,
identified 23%, 45% and 63%, respectively, of the sample aged 25 - 59 years
as exceeding these limits. The respective proportions in the present study were
24%, 51 % and 67%. It is likely that the estimates made by Lewis and his
colleagues 15 for achieving a satisfactory fall in cholesterol levels are relevant in
the context of our population. The mean serum cholesterol levels reported from
North Karelia in 1982 in the age group 30-59 were 6-3 mmol/l for men and
6-2 mmol/l for women.16 In the same age group in our sample, mean values of
5-92 and 5-87 mmol/l were found for men and women, respectively.
Although the role of HDL-cholesterol as a major independent riskfactor has been
disputed,'7 many studies testify to its importance as a predictor of coronary heart
disease.18 The mean level in 40-59-year-old males in the present study
was 1-12 mmol/l, similar to that found in the British Regional Heart Study
(1-15 mmol/1).)4 The methodology in that study, however, has been criticised.)8
Furthermore, the delays in preparation of samples incurred in that study by
sending to a central laboratory may have affected the precipitability. In subjects
aged over 50 years in the present study, the levels were similar to those found in
Framingham.l9
The proportion of males who smoked was comparable with that reported in other
local surveys, but in females it was higher.20 The proportion of females in
Northern Ireland aged 16 years and over smoking cigarettes in 1984 was
estimated as only 29%. It is possible that female smoking is more an urban
phenomenon in Northern Ireland. However, there was evidence from the
thiocyanate estimations that smoking was under-reported. The prevalence of
cigarette smoking was similar to Great Britain (1982: males 38%, females
33%).21 In North Karelia in 1982, 38% of males aged 25-59 years were
cigarette smokers 16 as compared with 36% in the present study.
The mean systolic blood pressures in 40-59-year-old males were markedly
lower than in the British Regional Heart Study: 10 134-6 versus 145-3 mmHg -
the difference was greatest in younger males. Conversely, the mean diastolic
blood pressure was higher in our study: 84-0 versus 82-2 mmHg. The Medical
Research Council's trial of treatment of mild hypertension9 identified 9% of
35-64-year-old men and women as having diastolic pressures of 90-109
mmHg (with a systolic pressure of below 200 mmHg). In our sample 20% of
those aged 35-64 years fulfilled these criteria: 25 % of men and 15% of
women. Diastolic blood pressure has been shown to be a better predictor than
systolic, at least in younger Norwegian men.22 The relationship between coronary
heart disease risk and diastolic blood pressure has lately been reaffirmed.23 The
'cross-over' phenomenon usually observed in cross-sectional studies, that above
50 years there are more hypertensive females than males, was not seen in this
study although a trend in that direction was observed. Johannson et al have
suggested that this phenomenon is an artefact caused by selective mortality in
hypertensive males.24
Concern about Northern Ireland's position in terms of coronary heart disease has
stimulated action. In 1984 the Northern Ireland Coronary Prevention Group
published its strategy for the primary prevention of coronary heart disease.25 The
recent launch of the 'Change of Heart' Programme26 by the Department of Health
and Social Services is appropriate as more than 80% ofthe population have been
shown to have at least one risk factor present.
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